Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Wilate in Previously Treated Patients With Severe Hemophilia A
Phase of Trial: Phase III
Latest Information Update: 01 Jul 2017
At a glance
- Drugs Factor VIII/von Willebrand factor (Primary)
- Indications Haemophilia A
- Focus Therapeutic Use
- Sponsors Octapharma
- 10 Jun 2017 Biomarkers information updated
- 19 Apr 2017 Trial design presented at the Hemostasis and Thrombosis Research Society Scientific Symposium 2017, according to an Octapharam USA media release.
- 10 Mar 2017 Status changed from not yet recruiting to recruiting.